• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

普通外科手术后尿潴留的预防:卡巴胆碱/地西泮与阿夫唑嗪的对照试验

Prevention of urinary retention after general surgery: a controlled trial of carbachol/diazepam versus alfusozine.

作者信息

Burger D H, Kappetein A P, Boutkan H, Breslau P J

机构信息

Department of Surgery, Rode Kruis Ziekenhuis, The Hague, The Netherlands.

出版信息

J Am Coll Surg. 1997 Sep;185(3):234-6.

PMID:9291399
Abstract

BACKGROUND

Postoperative urinary retention is a common complication after surgical procedures. It can cause bladder dilatation, infection, and even sepsis. Carbachol/diazepam and alfusozine have been reported to lower the incidence of postoperative urinary retention, but no study showed the benefits of these drugs in a randomized, placebo-controlled trial.

STUDY DESIGN

We used a double blind, placebo-controlled trial in which 249 patients with postoperative urinary retention were randomly assigned to receive carbachol/diazepam (n = 72), alfusozine (n = 82), or placebo (n = 95). The primary endpoint was miction within 2 hours after taking the medication.

RESULTS

There was no significant difference in miction frequency after taking the medication among the three groups (p = 0.31). The miction rate was 60% for patients in the alfusozine group, 61% in the carbachol/diazepam group, and 51% in the placebo group.

CONCLUSIONS

Alfusozine and carbachol/diazepam had no apparent benefit on the incidence of postoperative urinary retention.

摘要

背景

术后尿潴留是外科手术后常见的并发症。它可导致膀胱扩张、感染,甚至败血症。据报道,卡巴胆碱/地西泮和阿夫唑嗪可降低术后尿潴留的发生率,但尚无研究在随机、安慰剂对照试验中证明这些药物的益处。

研究设计

我们采用双盲、安慰剂对照试验,将249例术后尿潴留患者随机分为三组,分别接受卡巴胆碱/地西泮(n = 72)、阿夫唑嗪(n = 82)或安慰剂(n = 95)治疗。主要终点是服药后2小时内排尿。

结果

三组患者服药后的排尿频率无显著差异(p = 0.31)。阿夫唑嗪组患者的排尿率为60%,卡巴胆碱/地西泮组为61%,安慰剂组为51%。

结论

阿夫唑嗪和卡巴胆碱/地西泮对术后尿潴留的发生率无明显益处。

相似文献

1
Prevention of urinary retention after general surgery: a controlled trial of carbachol/diazepam versus alfusozine.普通外科手术后尿潴留的预防:卡巴胆碱/地西泮与阿夫唑嗪的对照试验
J Am Coll Surg. 1997 Sep;185(3):234-6.
2
Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study.接受前列腺癌125I近距离放射治疗的患者预防性使用坦索罗辛(哈乐):一项双盲安慰剂对照随机研究的最终报告
Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):164-9. doi: 10.1016/j.ijrobp.2004.09.036.
3
Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study.阿夫唑嗪10毫克每日一次用于治疗急性尿潴留:一项双盲安慰剂对照研究的结果
Urology. 2005 Jan;65(1):83-9; discussion 89-90. doi: 10.1016/j.urology.2004.07.042.
4
Prevention of postherniorrhaphy urinary retention with prazosin.
Am Surg. 1999 Jan;65(1):55-8.
5
Effectiveness of tamsulosin in prevention of post-operative urinary retention: a randomized double-blind placebo-controlled study.坦索罗辛预防术后尿潴留的有效性:一项随机双盲安慰剂对照研究。
Int Braz J Urol. 2014 Jan-Feb;40(1):30-6. doi: 10.1590/S1677-5538.IBJU.2014.01.05.
6
[Prevention and release of epidural-morphine-induced urinary retention with phenoxybenzamine and neostigmine].[用酚苄明和新斯的明预防和解除硬膜外吗啡引起的尿潴留]
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2000 Dec;22(6):595-6.
7
A comparison between oral antiarrhythmic drugs in the prevention of atrial fibrillation after cardiac surgery: the pilot study of prevention of postoperative atrial fibrillation (SPPAF), a randomized, placebo-controlled trial.心脏手术后口服抗心律失常药物预防心房颤动的比较:预防术后心房颤动的初步研究(SPPAF),一项随机、安慰剂对照试验。
Am Heart J. 2004 Apr;147(4):636-43. doi: 10.1016/j.ahj.2003.10.041.
8
Safety and tolerability of solifenacin add-on therapy to alpha-blocker treated men with residual urgency and frequency.索利那新附加疗法对接受α受体阻滞剂治疗但仍有尿急和尿频症状男性的安全性和耐受性
J Urol. 2009 Dec;182(6):2825-30. doi: 10.1016/j.juro.2009.08.023. Epub 2009 Oct 17.
9
Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.每日一次服用10毫克阿夫唑嗪可预防良性前列腺增生的整体临床进展,但不能预防急性尿潴留:一项为期2年的安慰剂对照研究结果。
BJU Int. 2006 Apr;97(4):734-41. doi: 10.1111/j.1464-410X.2006.06110.x.
10
Tamsulosin in the management of patients in acute urinary retention from benign prostatic hyperplasia.坦索罗辛用于治疗良性前列腺增生导致急性尿潴留的患者。
BJU Int. 2005 Feb;95(3):354-7. doi: 10.1111/j.1464-410X.2005.05299.x.

引用本文的文献

1
Can prophylactic tamsulosin reduce the risk of urinary retention after surgery? A systematic review and meta-analysis of randomized control trials.预防性坦索罗辛能否降低手术后尿潴留的风险?一项随机对照试验的系统评价和荟萃分析。
Int J Surg. 2023 Mar 1;109(3):438-448. doi: 10.1097/JS9.0000000000000267.
2
Medical and non-medical interventions for post-operative urinary retention prevention: network meta-analysis and risk-benefit analysis.预防术后尿潴留的医学和非医学干预措施:网状Meta分析和风险效益分析。
Ther Adv Urol. 2021 Jun 17;13:17562872211022296. doi: 10.1177/17562872211022296. eCollection 2021 Jan-Dec.
3
Systematic review of interventions for the prevention and treatment of postoperative urinary retention.
系统评价预防和治疗术后尿潴留的干预措施。
BJS Open. 2018 Nov 19;3(1):11-23. doi: 10.1002/bjs5.50114. eCollection 2019 Feb.
4
Female underactive bladder - Current status and management.女性膀胱功能减退——现状与管理
Indian J Urol. 2019 Jan-Mar;35(1):18-24. doi: 10.4103/iju.IJU_306_18.
5
Current pharmacological and surgical treatment of underactive bladder.当前治疗膀胱过度活动症的药理学和手术治疗方法。
Investig Clin Urol. 2017 Dec;58(Suppl 2):S90-S98. doi: 10.4111/icu.2017.58.S2.S90. Epub 2017 Nov 17.
6
Evaluating International Prostate Symptom Score (IPSS) in Accuracy for Predicting Post-Operative Urinary Retention After Elective Cataract Surgery: A Prospective Study.评估国际前列腺症状评分(IPSS)预测择期白内障手术后术后尿潴留的准确性:一项前瞻性研究。
Glob J Health Sci. 2015 Mar 26;7(7 Spec No):93-6. doi: 10.5539/gjhs.v7n7p93.
7
Drug-induced urinary retention: incidence, management and prevention.药物性尿潴留:发病率、管理与预防
Drug Saf. 2008;31(5):373-88. doi: 10.2165/00002018-200831050-00002.
8
Nosocomial infections after peripheral arterial bypass surgery.
World J Surg. 2007 Aug;31(8):1687-92. doi: 10.1007/s00268-007-9130-3.